Clinical Trial Update: Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating digital PCR screening of plasma HER2 amplification in advanced breast cancer patients treated with trastuzumab and pyrotinib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Advanced Breast Cancer | Phase 2 | Status: UNKNOWN